Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
AT Newall;
M Jit 
;
R Hutubessy;
(2014)
Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
PharmacoEconomics, 32 (12).
1247-.
ISSN 1170-7690
DOI: 10.1007/s40273-014-0232-0
;
R Hutubessy;
(2014)
Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
PharmacoEconomics, 32 (12).
1247-.
ISSN 1170-7690
DOI: 10.1007/s40273-014-0232-0
Full text not available from this repository.
Downloads